Tenax Therapeutics, Inc. (TENX)
 NASDAQ: TENX · Real-Time Price · USD
 7.47
 +0.24 (3.32%)
  At close: Oct 30, 2025, 4:00 PM EDT
7.43
 -0.04 (-0.54%)
  After-hours: Oct 30, 2025, 6:15 PM EDT
Tenax Therapeutics Employees
As of December 31, 2024, Tenax Therapeutics had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees 
 6
Change (1Y) 
 n/a
Growth (1Y) 
 n/a
Revenue / Employee 
 n/a
Profits / Employee 
 -$5,247,167
Market Cap 
298.73M
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 6 | 0 | - | 
| Dec 31, 2023 | 6 | -2 | -25.00% | 
| Dec 31, 2022 | 8 | -1 | -11.11% | 
| Dec 31, 2021 | 9 | -1 | -10.00% | 
| Dec 31, 2020 | 10 | 0 | - | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
TENX News
- 6 weeks ago - Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF - GlobeNewsWire
- 2 months ago - Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025 - GlobeNewsWire
- 2 months ago - Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 6 months ago - Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - Tenax: Phase 3 Heart Failure Program Continues With 2 Key Catalysts - Seeking Alpha
- 7 months ago - Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 7 months ago - Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 8 months ago - Tenax Therapeutics Announces $25 Million Private Placement - GlobeNewsWire